PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
3.740
-1.410 (-27.38%)
Jul 21, 2026, 4:00 PM EDT - Market closed
PolyPid Market Cap
PolyPid has a market cap or net worth of $71.71 million as of July 21, 2026. Its market cap has increased by 94.39% in one year.
Market Cap
71.71M
Enterprise Value
63.15M
1-Year Change
94.39%
Ranking
Category
Stock Price
$3.74
ChartMarket Cap Chart
Since June 26, 2020, PolyPid's market cap has decreased from $82.43M to $71.71M, a decrease of -13.01%. That is a compound annual growth rate of -2.27%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 71.71M | -0.67% |
| Dec 31, 2025 | 72.19M | 249.06% |
| Dec 31, 2024 | 20.68M | 229.16% |
| Dec 29, 2023 | 6.28M | -54.17% |
| Dec 30, 2022 | 13.71M | -87.27% |
| Dec 31, 2021 | 107.66M | -41.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 26, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeurAxis | 87.68M |
| NeOnc Technologies Holdings | 87.01M |
| Cognition Therapeutics | 86.71M |
| Adicet Bio | 84.95M |
| Champions Oncology | 84.71M |
| Alterity Therapeutics | 83.74M |
| Rani Therapeutics Holdings | 83.62M |
| MAIA Biotechnology | 81.49M |